logo
Tanium Explores the Future of Autonomous Endpoint Management at its European Converge World Tour Kickoff in Paris

Tanium Explores the Future of Autonomous Endpoint Management at its European Converge World Tour Kickoff in Paris

Business Wire13-05-2025
PARIS--(BUSINESS WIRE)-- Tanium, a leader in Autonomous Endpoint Management (AEM), brings its Converge World Tour to Paris to kick off its European tour. Held at the historic Hippodrome de Paris Longchamp, this event will bring together over 250 Tanium executives and product leaders, customers, and partners to explore new platform capabilities and share best practices.
Attendees will gain insights from Tanium leaders including CEO Dan Streetman who will open the event by discussing the growing importance of assurance in the face of an unpredictable threat landscape. Tanium SVP of Product Management, Randy Menon, and Tanium VP of AI, Harman Kaur, will further explore autonomous innovation and the expanding endpoint landscape, demonstrating how Tanium's AEM platform accelerates automation to strengthen endpoint security and performance at scale.
Tanium AEM empowers organizations to efficiently mitigate risk while maintaining operational resilience. By leveraging real-time insights to recommend and automate changes on endpoints across an organization's environment, Tanium AEM delivers a safe, scalable, and automated platform that helps IT and Security teams operate more efficiently and confidently, at scale.
'With our evolution to Tanium AEM, we are at the forefront of a seismic shift,' said Dagobert Levy, Vice President EMEA South, Tanium. 'At Converge World Tour Paris, we are delivering valuable insights into AI capabilities and automation, sharing success stories from our customers and partners, and equipping attendees with practical strategies to transform the frontlines of IT management and cybersecurity.'
At the event, Tanium will showcase its latest capability, the Tanium Integrations Gallery, which allows users to seamlessly discover, deploy, and manage joint solutions. It also enables users to explore integration possibilities across platforms such as Microsoft and ServiceNow, all from within the Tanium platform. This helps Tanium customers maximize the value of their investments, reduce complexity, and minimize risk.
Converge World Tour Paris will feature highlights, including:
Customer thought leadership sessions with two major French media providers and a leading French food processor.
An exclusive workshop with ServiceNow that will enable attendees to get the most value from their ServiceNow investments through integrated automation strategies.
Technical breakouts and hands-on labs including:
'Automating Vulnerability Management' led by Tanium Sr. Director, Product Management, Stephanie Aceves.
'Close the loop: Threat Hunting and Autonomous Remediation' with Tanium Sr. Director, Security and Product Design Research, Melissa Bischoping.
'Optimizing with APIs and Integrations' with Tanium Sr. Director, Product Management, Shelly Sahani.
Tanium Partner Academy, hosted by Tanium SVP Global Partner Sales, Tony Beller, where the regional winners of the 2025 Partner Awards will be announced.
For further information about an upcoming Converge World Tour event in a city near you, please visit: https://www.tanium.com/converge-world-tour.
About Tanium
Tanium Autonomous Endpoint Management (AEM) offers the most comprehensive solution for intelligently managing endpoints across industries, providing capabilities for asset discovery and inventory, vulnerability management, endpoint management, incident response, risk and compliance, and digital employee experience. The platform supports 34 million endpoints worldwide, including 40% of the Fortune 100, delivering increasingly efficient operations and an improved security posture at scale, with confidence, and in real-time. For more information on The Power of Certainty™, visit www.tanium.com and follow us on LinkedIn and X.
Legal Disclaimer
The information described herein is for general informational purposes only. This information is not a commitment, warranty, offer, promise, or legal obligation for us to deliver any future products, features, or functionality, and is not intended to be, and shall not be deemed to be, incorporated into any contract. The actual timing of any product, feature, or functionality that is ultimately made available may be different from what is described.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

CyberPower Wins 2025 CRN® Tech Innovator Award for its PFC Sinewave 1U Rackmount UPS Systems
CyberPower Wins 2025 CRN® Tech Innovator Award for its PFC Sinewave 1U Rackmount UPS Systems

Business Wire

time10 minutes ago

  • Business Wire

CyberPower Wins 2025 CRN® Tech Innovator Award for its PFC Sinewave 1U Rackmount UPS Systems

SHAKOPEE, Minn.--(BUSINESS WIRE)-- Cyber Power Systems (USA), Inc., a leader in power protection and power management products, announced today its PFC Sinewave 1U Rackmount UPS (uninterruptible power supply) systems were named the overall winner in the CRN® Tech Innovator Awards in the power protection and management category. The annual CRN awards spotlight innovative technology vendors in the IT channel. The winners were selected in 33 distinct technology categories across areas such as cloud, storage, networking, and security by a panel of CRN editors after closely reviewing hundreds of vendor entries and solution provider testimonials. The judges selected winners based on multiple criteria, including key capabilities, uniqueness, technological ingenuity, and ability to address customer and partner technology needs. As part of its best-selling PFC Sinewave UPS product line, CyberPower launched the 1U-size PFC Sinewave series in late 2024 to address a need for compact rackmount power protection suitable for a variety of security, audio/visual, edge computing, telecom, and networking environments. 'Many of these IT environments demand professional power protection and sine wave output in a minimum footprint, specifically for wall mount and small server racks,' said Mike Dresen, lead product manager at CyberPower. 'You can't get more compact than our line of PFC Sinewave 1U Rackmount UPS systems. In addition to sine wave output, we packed these compact units with premium features like optional remote management capabilities, a color LCD panel, and EMI/RFI noise filtering.' The CyberPower PFC Sinewave 1U Rackmount UPS systems are available in four models and varying battery capacities and depth dimensions: CP500PFCRM1U, 500 VA/300 Watts; CP700PFCRM1U, 700 VA/400 Watts; CP1000PFCRM1U, 1000 VA/600 Watts; and CP1500PFCRM1U, 1500 VA/900 Watts. Each UPS system can be remotely monitored and managed using an optional CyberPower remote management card or cloud card via software from CyberPower: PowerPanel® Business software or the PowerPanel® Cloud app, respectively. The solutions facilitate convenient management and monitoring of CyberPower UPS systems from iOS and Android mobile devices as well as desktop applications. Dresen added: 'Having remote capability allows IT pros to check, manage and restart power without physically going out to the location so this cuts down on time and cost.' 'Each of the 2025 CRN Tech Innovators Award winners is a standout offering that reimagines what's possible in the IT channel,' said Jennifer Follett, VP, U.S. content and executive editor at CRN, The Channel company. 'Each creates the opportunity to build bold solutions that solve real-world challenges for end users and drive success for channel partners. We congratulate our winners for their commitment to innovation, partner success, and customer impact, and we can't wait to see how they continue to push technology boundaries forward.' The Tech Innovators Award winners are featured in the August 2025 issue of CRN and can be viewed online at Note to editor: an image is available at About Cyber Power Systems (USA), Inc. CyberPower designs and manufactures uninterruptible power supply systems, power distribution units, surge protectors, remote management hardware, power management software, mobile chargers and connectivity products. The company serves customers in enterprise, corporate, government, education, healthcare and small office/home office environments. CyberPower products are available through authorized distributors and sold by value-added resellers, system integrators, managed service providers, select retailers, and online resellers. For more information, visit About The Channel Company The Channel Company enables breakthrough IT channel performance with our dominant media, engaging events, expert consulting and education, and innovative marketing services and platforms. As the channel catalyst, we connect and empower technology suppliers, solution providers, and end users. Backed by more than 40 years of unequalled channel experience, we draw from our deep knowledge to envision innovative new solutions for ever-evolving challenges in the technology marketplace.

CUPE: Air Canada Flight Attendants Forced to Issue Strike Notice to End Unpaid Work
CUPE: Air Canada Flight Attendants Forced to Issue Strike Notice to End Unpaid Work

Business Wire

time10 minutes ago

  • Business Wire

CUPE: Air Canada Flight Attendants Forced to Issue Strike Notice to End Unpaid Work

TORONTO--(BUSINESS WIRE)--The Air Canada Component of CUPE has issued a 72-hour strike notice to Air Canada after the airline refused to recognize that flight attendants should be paid for all their time on the job. Air Canada responded by issuing a 72-hour lockout notice. "For the past nine months, we have put forward solid, data-driven proposals on wages and unpaid work, all rooted in fairness and industry standards," said Wesley Lesosky, President of the Air Canada Component of CUPE. "Air Canada's response to our proposals makes one thing clear: they are not interested in resolving these critical issues." The airline is also refusing to increase flight attendant wages to match industry standards, inflation, or even federal minimum wage. Entry-level flight attendant wages have only gone up $3 per hour since 2000 while inflation has increased by 69% in the same timeframe. "Our locals have had to set up food banks in our union offices for junior members who cannot afford groceries," said Lesosky. "Our members need and deserve a fair wage increase that makes everyone whole for the skyrocketing cost of living, and one that lifts our junior flight attendants out of poverty." Air Canada's offer of an 8% wage increase in year one would not even recoup the 9% that flight attendants have lost in purchasing power over the course of their previous contract. It is, in effect, a pay cut. Air Canada is clearly banking on the federal government bailing them out by pre-empting flight attendants' Charter-protected right to take job action. "When we stood together, Air Canada didn't come to the table in good faith," Lesosky added. "Instead, they called on the federal government to step in and take our rights away. Despite the company's abhorrent attempts to pre-emptively take away our Charter rights, we remain at the bargaining table, ready to negotiate and avert a shutdown.'

Seek Labs Unveils Investigational, Equipment-Free Molecular Prototype for MTB on Rapid-Deploy SeekIt™ Platform
Seek Labs Unveils Investigational, Equipment-Free Molecular Prototype for MTB on Rapid-Deploy SeekIt™ Platform

Business Wire

time10 minutes ago

  • Business Wire

Seek Labs Unveils Investigational, Equipment-Free Molecular Prototype for MTB on Rapid-Deploy SeekIt™ Platform

SALT LAKE CITY--(BUSINESS WIRE)--Seek Labs, a biotech company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, today announced a significant advancement in the global fight against tuberculosis (TB) with an investigational prototype for Mycobacterium tuberculosis (MTB) detection on its SeekIt™ platform. In internal analytical testing, the MTB SeekIt test delivered accurate results in under 60 minutes. Importantly, this innovation addresses a key limitation that has historically hindered effective TB diagnostics: breaking apart MTB's waxy, lipid-rich cell wall to gain access to detectable genetic material. In internal testing, SeekIt's proprietary chemical lysis step achieved this in just 15 minutes without heat, mechanical disruption, or complex lab tools and skilled operators. Seek Labs achieved a functional investigational prototype in one quarter by leveraging its suite of in-house, pre-validated diagnostic technologies, focusing new innovation efforts on the MTB-specific lysis step. Share Seek Lab's MTB test demonstrates the speed, adaptability, and field-readiness of the modular SeekIt platform. All SeekIt's components—lysis chemistry, extraction, amplification, and detection—are proprietary to Seek Labs, exclusively discovered and developed in-house, and have been internally validated for performance and integration across multiple applications. The Global TB Testing Gap TB kills more than 1.25 million people each year, with nearly one in three cases going undiagnosed. In high-burden, resource-limited settings, centralized molecular tests face major hurdles: Pathogen complexity: MTB's waxy, lipid-rich cell wall has proven intractable to portable lysis methods for decades. Infrastructure dependence: Gold-standard molecular tests require expensive, power-intensive instruments, refrigeration, and highly skilled (or trained) operators. Sample limitations: Sputum collection is challenging for many patients and can deter testing. 'TB diagnostics have long been limited by gaps in both infrastructure and innovation that have often meant severe consequences for patient care and public health,' said Jared Bauer, CEO of Seek Labs. 'Our rapid, point-of-care SeekIt MTB test is designed to enable molecular-level detection in settings where access to equipment and electricity may be limited.' From Sample to Result: A Simplified Workflow At the core of the MTB SeekIt test is a proprietary, single-step chemical lysis buffer, involving a specially-formulated solution that disrupts MTB cells to release their genomic DNA. This breakthrough innovation takes just 15 minutes at room temperature, while competing methods (high-heat incubation or mechanical bead-beating) require longer times plus expensive equipment, specialized technicians, and complex infrastructure. More importantly, the integrated SeekIt test means the lysate itself flows seamlessly into SeekIt's downstream test components: Seek Extraction™ — A proprietary membrane-based binding system, developed and validated by Seek Labs, that rapidly captures MTB DNA without lab instruments. In validation testing, the MTB DNA yield for Seek Extraction was consistently more than 70% when compared to leading spin-column kits. Seek Amplification™ — A proprietary process that exponentially copies DNA at a constant temperature, detecting as few as 10 MTB genomic copies in 30 minutes without thermal cycling (internally validated), the conventional lab-based method. Molecular Lateral Flow Assay (mLFA) — A test strip that delivers clear, visual results in minutes indicating the presence of amplified DNA in a manner that can be optionally paired with the SeekIt mobile app for digital analysis and connectivity. Speed as a Strategy Conventional development of a molecular test for MTB can take a year or more. Seek Labs achieved a functional investigational prototype in one quarter by leveraging its suite of in-house, pre-validated diagnostic technologies, focusing new innovation efforts on the MTB-specific lysis step. This rapid-deployment approach illustrates how SeekIt can be rapidly developed for numerous high-priority diseases in record time. 'This was more than a fast project; it's proof of our platform's flexibility,' said Kim Wirthlin, Chief Strategy Officer. 'By focusing our innovation on the MTB-specific lysis step for compatibility with our downstream isothermal amplification, we solved one of TB diagnostics' toughest technical challenges and produced a functional investigational prototype in a single quarter.' From Conference to Collaboration Seek Labs will debut the MTB SeekIt prototype at the 2025 Next Generation Dx Conference (August 18–20, 2025, Washington, D.C.), including: Podium Presentation — Enabling Point of Care Diagnostics Track, Tuesday, August 19 at 10:00 AM ET. Scientific Poster — Detailing the proprietary lysis chemistry, rapid development process, and validation data. Seek Labs is actively seeking partners across global health (ministries of health, TB-focused NGOs, and diagnostics distributors in high-burden regions such as sub-Saharan Africa and Southeast Asia) to advance the MTB SeekIt test through clinical validation, regulatory approval, and deployment. 'Innovation means nothing if it doesn't reach people,' said Bauer. 'We want to work with those who share our vision to advance development of accurate, accessible TB testing solutions wherever they're needed most.' About Seek Labs At Seek Labs, we don't wait for change—we build it. We're pursuing the breakthroughs the world can't wait for by developing programmable 'seek-and-destroy' therapeutics and point-of-care molecular diagnostics that close the gap between outbreak and intervention. At the core of this mission is a layered architecture: BioSeeker™ serves as the Intelligence Layer, continuously mapping conserved viral vulnerabilities in real time; these insights activate our Deployment Layers (PTAP™ for programmable therapeutics and SeekIt™ for molecular diagnostics), forming a full-stack development engine designed to accelerate response, innovation, and impact across global health. Headquartered in Salt Lake City, Seek Labs is a proud member of BioHive, Utah's collaborative life sciences ecosystem. Together with our partners, we're building faster, smarter solutions for the world's most urgent health challenges. Forward-Looking Statements and Regulatory Disclaimer This press release contains forward-looking statements, including statements regarding development timelines, clinical validation, regulatory pathways, and potential collaborations. Forward-looking statements are based on current expectations and assumptions and are subject to risks and uncertainties—including scientific, regulatory, manufacturing, clinical, and commercial risks—that could cause actual results to differ materially. The MTB SeekIt assay is an investigational device. Limited by Federal law to investigational use.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store